Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )

Name: Sintilimab or Placebo With Chemotherapy in Esophageal Squamous Cell Carcinoma ( ORIENT-15 )
Published: 2018
License: Public Domain

Innovent Biologics (Suzhou) Co. Ltd. · 2018

ClinicalTrials.gov · Datasets · License: Public Domain · 2018

Open Source ↗

carcinoma cisplatin esophageal-squamous-cell-carcinoma neoplasms paclitaxel

esophageal squamous cell carcinoma, escc, esophageal cancer, esophageal neoplasms, esophageal neoplasms malignant, neoplasms, squamous cell, esophageal diseases, carcinoma, squamous cell, gastrointestinal diseases, paclitaxel, cisplatin, fluorouracil

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 862401
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.